Ladon report: marker association counts
Marker association counts of Treatment benefit (predictive biomarker) from bulk RNA-seq
Prose: of 304 marker-PFS associations significant before adjustment for Ladon prognosis, 24 remained significant (Benjamini-Hochberg within trial, arm and condition over 550 markers). Figure 7 prints '106 significant' and '0 retained' for its default trial selection; its toggle lists POPLAR, OAK and IMmotion151, while the Methods analyse four trials including IMmotion150; its caption says '550 total' although only markers significant before adjustment are displayed
Descriptive fact transcribed from the pinned source with its own locator.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
7 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Claimed field marker_association_counts Context-only references | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale The figure's 106 and 0 are not tied to a named trial in the PDF, and the caption's 550 is the size of the screened marker family, not the number displayed. Context-only references | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Source location Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Context-only references | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed value Prose: of 304 marker-PFS associations significant before adjustment for Ladon prognosis, 24 remained significant (Benjamini-Hochberg within trial, arm and condition over 550 markers). Figure 7 prints '106 significant' and '0 retained' for its default trial selection; its toggle lists POPLAR, OAK and IMmotion151, while the Methods analyse four trials including IMmotion150; its caption says '550 total' although only markers significant before adjustment are displayed Context-only references | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Description Descriptive fact transcribed from the pinned source with its own locator. Context-only references | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: subject ladon-20261115-task-treatment-benefit Context-only references | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Name Ladon report: marker association counts Context-only references | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Original source · Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Technical metadata and extraction receipts
Stable ID: ladon-20261115-claim-association-counts
- field
- marker_association_counts
- rationale
- The figure's 106 and 0 are not tied to a named trial in the PDF, and the caption's 550 is the size of the screened marker family, not the number displayed.
- review
- artifact sha256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c; method: pdf-text-parse; source-hash-verification; automated-source-review; method note: Independent review pass. All 216 non-result records were checked by review/check_claim_quotes.py, written for this pass, which looks for every quoted phrase and every number a record states in the text of the sources that record cites: the pinned PDF's pdftotext -layout text layer, and for records citing them the announcement page and the Figure 6 page, whose embedded DATA object is searched as text rather than stripped as script. 182 quoted phrases and 1,136 numbers; three were not found by search and each was then read by hand and accepted, with the reason recorded in review/claim-quote-check.tsv (a sum the field itself labels as the extractor's, a row label the text layer breaks across two lines, and a locator joining a panel's two printed header lines with a comma). Pages 6 to 10, 12, 13, 15 to 17, 19, 20, 24 to 28, 33, 35 and 39 were read in full, and these were checked against the records in particular: the trial, endpoint and patient counts of pages 12, 13 and 15 against the dataset and dataset-subset records; the fitting procedures of pages 12 and 13 against each configuration; the geometric-mean and size-weighted aggregations of page 13 against the Figure 3 and Figure 5 protocols; the reimplementation sentence on page 39 against the CIBERSORT and DWLS method records; and the bootstrap statements on pages 28 and 39 against the stored uncertainty methods and resample counts. Pages the records cite but that were not read line by line (pages 11, 14, 18, 22, 29, 38 and 40 to 43) are covered by the quote and number check alone.; note: Re-read at the locator this record names; it matched.; retrieval url: https://zenodo.org/api/records/24157116/files/Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf/content; reviewed at: 2026-11-15T23:30:00Z; reviewer: claude; reviewer note: Claude review agent, independent of the extractor; no human review claimed. Transcription was checked against the pinned sources, which is not reproduction: nothing was rerun and no value was recomputed.
- source locator
- Page 17 prose; Figure 7 (page 17) and caption; page 20, Methods 'Association models and endpoints'
- value
- Prose: of 304 marker-PFS associations significant before adjustment for Ladon prognosis, 24 remained significant (Benjamini-Hochberg within trial, arm and condition over 550 markers). Figure 7 prints '106 significant' and '0 retained' for its default trial selection; its toggle lists POPLAR, OAK and IMmotion151, while the Methods analyse four trials including IMmotion150; its caption says '550 total' although only markers significant before adjustment are displayed